Lawmakers Push IRS for Cannabis Tax Guidance After Rescheduling
Congressional members are calling on the IRS to issue immediate tax guidance for cannabis operators following the DEA's rescheduling decision.

Top view of tax forms, a calculator, and pen for tax preparation.
Congressional Letter Demands Tax Clarity
The letter, signed by multiple House and Senate members, requests that the IRS clarify how the rescheduling affects Section 280E of the Internal Revenue Code. Under current law, 26 U.S.C. § 280E prohibits businesses trafficking in Schedule I or II controlled substances from deducting ordinary business expenses. With cannabis moving to Schedule III, operators expect relief from this tax burden that's cost the industry billions annually.
Without clear IRS guidance, cannabis businesses face uncertainty in their 2026 tax planning. That's the lawmakers' central concern. Many operators have already begun restructuring their accounting in anticipation of 280E relief.
280E Relief Could Save Industry Billions
Removal of 280E restrictions would allow cannabis operators to deduct payroll, rent, and other ordinary business expenses for the first time since state-legal markets emerged. Industry analysts estimate the change could reduce effective tax rates from 70-80% to standard corporate rates of 21-35%.
But the effective date of 280E relief remains unclear. The DEA's final rule rescheduling cannabis took effect May 1, 2026, yet the IRS hasn't issued guidance on whether the tax change applies retroactively to January 1, 2026, or only prospectively from the rule's effective date.
Timing Pressure for Mid-Year Tax Filings
The lawmakers' letter notes that businesses need guidance before the June 15, 2026 deadline for second-quarter estimated tax payments. Without IRS clarification, operators don't know whether to calculate payments under the old 280E regime or the new Schedule III framework.
Several multi-state operators have stated in recent earnings calls that they're reserving cash for potential tax liabilities under both scenarios until the IRS provides definitive guidance. It's a costly hedge.
IRS Has Not Commented on Timeline
The IRS hasn't publicly responded to the congressional request or indicated when it will issue guidance. The agency typically releases tax guidance through revenue rulings, revenue procedures, or notices published in the Internal Revenue Bulletin.
Tax attorneys have noted that the IRS could take months to formalize guidance, though the agency has authority to issue interim notices more quickly in response to urgent regulatory changes. For context on the broader rescheduling process, see the CannIntel topic hub on DEA rescheduling.
What Operators Should Watch
Cannabis operators should monitor the IRS website for notices and consult tax counsel before filing second-quarter payments. The next key date is June 15, when Q2 estimated payments are due. Industry groups including the National Cannabis Industry Association have also submitted formal comments to the IRS requesting expedited guidance.
Beyond the effective date question, the IRS will need to address transition rules for businesses that filed 2025 returns under 280E but will operate under Schedule III rules for part or all of 2026.
For complete background, history, and our ongoing coverage of this story:
Open the CannIntel topic hub →Frequently asked questions
What is Section 280E and how does it affect cannabis businesses?
Section 280E of the Internal Revenue Code prohibits businesses trafficking in Schedule I or II controlled substances from deducting ordinary business expenses like payroll and rent. This has resulted in effective tax rates of 70-80% for state-legal cannabis operators, far higher than typical corporate rates.
When does the 280E tax relief take effect for cannabis businesses?
The effective date remains unclear. The DEA's rescheduling rule took effect May 1, 2026, but the IRS has not clarified whether tax relief applies retroactively to January 1, 2026, or only from May 1 forward. This ambiguity is why lawmakers are pressing for immediate guidance.
How much could cannabis businesses save if 280E is eliminated?
Industry analysts estimate that removing 280E restrictions could reduce effective tax rates from 70-80% to standard corporate rates of 21-35%, potentially saving the industry billions of dollars annually in deductible business expenses.
What should cannabis operators do while waiting for IRS guidance?
Operators should consult tax counsel before filing second-quarter estimated payments due June 15, 2026. Many multi-state operators are reserving cash for potential liabilities under both the old 280E framework and the new Schedule III rules until the IRS provides definitive guidance.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Laws

Illinois Proposes Rule Changes to Cannabis Licensing and Social Equity
The state's Department of Financial and Professional Regulation has opened a public comment period on amendments to adult-use and medical cannabis regulations.

Minnesota merges medical and adult-use cannabis supply chains
State regulators unified the two markets effective May 28, 2026, ending separate inventory tracking.

DOJ Order Clarifies Tribal Cannabis Programs Under Schedule III
Justice Department guidance addresses how cannabis rescheduling affects tribal operators under existing federal frameworks.
More from the newsroom

Marc Shepard Built NECANN for the Locals. Now the Fight Comes Home
The Northeast cannabis expo founder reflects on regional markets, consolidation pressure, and why hyperlocal culture still beats MSO playbooks.

CO2 Supplementation: When the Math Works and When It Doesn't
Running 1200-1500 ppm CO2 can add 20-30% yield, but only if your room is sealed, your light is dialed, and you can stomach the power bill.

Regular Cannabis Users Require Higher Anesthesia Doses for Wisdom Teeth
New research links habitual cannabis consumption to increased sedative requirements during oral surgery procedures.